MENUMENU
  • Home
  • 회사 소개
    • About us
  • 제공 서비스
    • 산업용 화학물질
      • 아시아 및 오세아니아
        • 중국 신규화학물질 등록 및 신고 서비스 (MEE Order No.12)
        • 중국 위험화학물질 등록서비스
        • 중국 위험화학물질 경영허가증 신청 서비스
        • 중국 내 화학물질 전반 과정 관리
        • 중국 마약류 화학물질 허가 및 신고 신청 서비스
        • 중국 SDS 및 GHS 서비스
        • 대만 화학물질 등록 서비스(TCCSCA/OSHA)
        • 대만 우선관리화학물질 신고 서비스
        • 대만 SDS의 CBI 비밀유지 신청
        • 화학물질의 등록 및 평가 등에 관한 법률 서비스 (K-REACH)
        • 한국 물질안전보건자료(MSDS) 대응 서비스 (K-OSHA)
        • 인도 BIS 인증
        • 인도 REACH 규정 서비스
        • 일본 화심법 서비스(CSCL)
        • 필리핀 화학물질 규제 서비스
        • 말레이시아 유해물질 EHSNR 신고
        • 호주 AICIS 산업화학물질법
        • 뉴질랜드HSNO법규
      • 유럽&아메리카
        • 유럽 REACH 서비스 (EU REACH)
        • EU UFI 신청 및 독성센터 신고(PCN)
        • EU CLP 규정서비스
        • EU POPs 규정 서비스
        • 기술규정(EURASIA REACH)
        • EU SCIP 통보 서비스
        • 유럽 고위험성우려물질 신고 서비스 (EU SVHC Notification)
        • EU C&L 통보 서비스
        • EU 산림전용방지법 (EUDR) 서비스
        • CUS코드 조회 및 신청 서비스
        • PPORD 신고 서비스
        • 영국 화학물질 규제 대응 서비스(UK REACH)
        • 튀르키예 REACH 대응 서비스 (KKDIK)
        • 우크라이나 REACH 등록
        • 미국 독성물질관리법 서비스 (TSCA)
        • 캐나다 신규 물질 신고 서비스 (CEPA)
        • 라틴 아메리카 화학물질 관리 규제
        • 브라질 REACH 등록
      • 글로벌 규제
        • 24시 비상연락망 서비스 (24HR Global Emergency Telephone Contact Number Service)
        • 해외 SDS / Label 작성 서비스 (SDS / Label service)
        • CAS 번호 조회 신청 서비스
        • 글로벌 GHS/SDS/라벨 서비스
        • GreenScreen 평가 및 인증
        • ChemFORWARD 평가 및 SAFER™ 마크 신청
    • 농업용 화학물질
      • 살충제 등록
        • 중국 농약 규제 대응 서비스
        • 중국 동일원제(모약) 등록
        • 중국 신규 농약 등록
        • EU 농약(PPP) 등록 서비스
        • EU TE 평가 – EU 원제 동등성 평가
        • 미국 EPA 농약 등록 서비스
      • 살생물제 등록
        • EU 살생물제 관리 규정(EU-BPR)
        • 생활화학제품 및 살생물제의 안전관리에 관한 법률 (K-BPR)
      • 비료 등록
        • 중국 비료 관리 규정
      • 규제 대응
        • 농약과 소독제 위험평가
    • 식품 및 식품 접촉물질
      • 규제 대응
        • 법규요구/중국 수입식품 라벨 심사 및 번역
        • 중국 신식품 원료 등록
        • 동남아시아 식품 규제 서비스
        • EU 신식품(Novel Food, NF) 신청
        • 미국 건강기능식품(DS) 규제 및 라벨링 서비스
        • 미국 NDI 신규 건강기능식품 성분 인증
        • 미국 GRAS 인증
        • 미국 식품 준수 및 라벨링 서비스
        • 미국 FDA 인증(생산 시설) 등록 서비스
      • 식품 접촉 물질
        • 중국 식품접촉물질과 제품
        • 일본 식품 접촉 물질 규제 서비스
        • 미국 식품 접촉물질 통지 서비스
        • 미국 식품 접촉 재생 플라스틱 등록
        • 미국 FDA 식품 접촉 통지 FCN 신청
        • 미국 FDA 재활용 플라스틱 NOL 신청
        • 미국 식품접촉물질 적합성 선언(DoC)
        • EU식품 접촉 재료 등록 서비스
        • EU EFSA 식품 접촉 재생 플라스틱 등록
    • 화장품
      • 중국
        • 중국 화장품(완제품)
        • 중국 화장품 완제품 신고 및 등록
        • 중국 화장품 신원료 등록 및 신고
        • 중국 화장품 원료 보고 서비스
        • 중국 화장품효능 평가
        • 중국 치약 신고 서비스
      • 아시아
        • 한국 화장품(완제품)
        • 베트남 화장품(완제품)
        • 일본 화장품(완제품)
        • 아세안 화장품 규제 서비스
        • 말레이시아 화장품(완제품)
        • 태국 화장품 등록 서비스
        • 인도네시아 화장품(완제품)
        • 싱가포르 화장품(완제품)
        • 대만 화장품 등록 서비스
        • 대만 화장품 PIF 보고서 작성 서비스
      • 미국 및 유럽
        • 미국 화장품(완제품) | MoCRA
        • EU&UK 화장품(완제품)
        • 영국 화장품 SCPN신고 서비스
        • EU CPNP(유럽연합 화장품 신고)서비스
        • EU 및 영국 화장품 책임자(RP)제도
        • EU 화장품 수출 규정 서비스
        • 화장품 안전성평가 CPSR(유럽연합 및 영국)
      • 기타
        • PCPC INCI Name 등록
        • 기사용 원료(ECI)
        • 화장품 안전성 평가
        • 원료 안전성 평가
        • 신원료(NCI)
  • 최신 뉴스
  • ChemLinked
  • 문의하기
  • Language
    • 中文
    • English
    • 日本語
  • Home 
  • > 未分类

Chinese Drug Administration

Background China\’s pharmaceutical industry is experiencing rapid development these years. The growth can\’t be achieved without the incentive policies introduced by the Chinese government. The government has been working to improve the pharmaceutical regulatory environment and ensure that medicines are easily accessible for Chinese patients. Given the growing concern of the Chinese people for health and the huge consumption potential of the Chinese pharmaceutical market, more and more international pharmaceutical companies are targeting this market. To help relevant industry enterprises and individuals understand the current pharmaceutical regulations and the future trend in China, the BaiPharm team under ChemLinked plans to launch this webinar series in the upcoming months of 2021. There will be at least 10 topics, covering China\’s drug regulatory authorities, major laws

May. 06th, 2021

Chinese Drug Legislative Framework

Background China\’s pharmaceutical industry is experiencing rapid development these years. The growth can\’t be achieved without the incentive policies introduced by the Chinese government. The government has been working to improve the pharmaceutical regulatory environment and ensure that medicines are easily accessible for Chinese patients. Given the growing concern of the Chinese people for health and the huge consumption potential of the Chinese pharmaceutical market, more and more international pharmaceutical companies are targeting this market. To help relevant industry enterprises and individuals understand the current pharmaceutical regulations and the future trend in China, the BaiPharm team under ChemLinked plans to launch this webinar series in the upcoming months of 2021. There will be at least 10 topics, covering China\’s drug regulatory authorities, major laws

May. 06th, 2021

Chinese Drug Legislative Framework

Background China\’s pharmaceutical industry is experiencing rapid development these years. The growth can\’t be achieved without the incentive policies introduced by the Chinese government. The government has been working to improve the pharmaceutical regulatory environment and ensure that medicines are easily accessible for Chinese patients. Given the growing concern of the Chinese people for health and the huge consumption potential of the Chinese pharmaceutical market, more and more international pharmaceutical companies are targeting this market. To help relevant industry enterprises and individuals understand the current pharmaceutical regulations and the future trend in China, the BaiPharm team under ChemLinked plans to launch this webinar series in the upcoming months of 2021. There will be at least 10 topics, covering China\’s drug regulatory authorities, major laws

May. 06th, 2021

Registration of APIs, Pharmaceutical Excipients and Packaging Materials in China

Background China\’s pharmaceutical industry is experiencing rapid development these years. The growth can\’t be achieved without the incentive policies introduced by the Chinese government. The government has been working to improve the pharmaceutical regulatory environment and ensure that medicines are easily accessible for Chinese patients. Given the growing concern of the Chinese people for health and the huge consumption potential of the Chinese pharmaceutical market, more and more international pharmaceutical companies are targeting this market. To help relevant industry enterprises and individuals understand the current pharmaceutical regulations and the future trend in China, the BaiPharm team under ChemLinked plans to launch this webinar series in the upcoming months of 2021. There will be at least 10 topics, covering China\’s drug regulatory authorities, major laws

May. 06th, 2021

Registration of APIs, Pharmaceutical Excipients and Packaging Materials in China

Background China\’s pharmaceutical industry is experiencing rapid development these years. The growth can\’t be achieved without the incentive policies introduced by the Chinese government. The government has been working to improve the pharmaceutical regulatory environment and ensure that medicines are easily accessible for Chinese patients. Given the growing concern of the Chinese people for health and the huge consumption potential of the Chinese pharmaceutical market, more and more international pharmaceutical companies are targeting this market. To help relevant industry enterprises and individuals understand the current pharmaceutical regulations and the future trend in China, the BaiPharm team under ChemLinked plans to launch this webinar series in the upcoming months of 2021. There will be at least 10 topics, covering China\’s drug regulatory authorities, major laws

May. 06th, 2021

Get to Grips with Infant Formula Branding and Marketing in China

Background Since 2020, multinational infant formula giants have been facing compounding problems in the Chinese market, including falling birth rate, obstructed international logistics, the Daigou exodus, and intensified competition from local counterparts. However, they still regard Chinese market as a growth engine and have deployed multi-pronged strategies to win out. Branding and marketing cannot be ignored for any brands who aim to enhance fame and popularity in China. Localized marketing can help brands integrate into the local market as soon as possible and get twice the result with half the effort. ChemLinked Market Research Analyst Shine Hu will share her insights into feasible branding and marketing approaches for infant formula brands in China and help foreign brands find more opportunities in the Chinese infant formula market. Contents Part 1 Why branding and marketing matter? Part 2 Methods of doing infant formula branding and marketing in China Part 3 Case studies…

Apr. 23rd, 2021

Get to Grips with Infant Formula Branding and Marketing in China

Background Since 2020, multinational infant formula giants have been facing compounding problems in the Chinese market, including falling birth rate, obstructed international logistics, the Daigou exodus, and intensified competition from local counterparts. However, they still regard Chinese market as a growth engine and have deployed multi-pronged strategies to win out. Branding and marketing cannot be ignored for any brands who aim to enhance fame and popularity in China. Localized marketing can help brands integrate into the local market as soon as possible and get twice the result with half the effort. ChemLinked Market Research Analyst Shine Hu will share her insights into feasible branding and marketing approaches for infant formula brands in China and help foreign brands find more opportunities in the Chinese infant formula market. Contents Part 1 Why branding and marketing matter? Part 2 Methods of doing infant formula branding and marketing in China Part 3 Case studies…

Apr. 23rd, 2021

Decoding India’s New Cosmetics Rules 2020

Background The Cosmetic Rules 2020 was published in GSR 763 (e) by the India Ministry of Health and Family Welfare and enforced from December 15th, 2020. The new rules have streamlined, clarified the regulatory requirements and standards on the import, manufacture, and distribution of cosmetics in India. The new rules enhance accountability for importers and manufacturers with respect to the quality of their cosmetic products. The digitalization of the regulatory process going forward is also bound to increase efficiencies and make the application process smooth and less time-consuming to the importers and manufacturers. To help enterprises better cope with the Cosmetic Rules 2020, ChemLinked invited Ms. Rucha Kelkar, the founder of Praha Regulatory Consultants, to detail the key changes brought by the new rules, the regulatory requirements of imported cosmetics, and advice on regulatory compliance. Contents Cosmetic market in India Introduction to the Cosmetics Rules 2020 Comparisons between the old and new rules…

Apr. 22nd, 2021

Decoding India’s New Cosmetics Rules 2020

Background The Cosmetic Rules 2020 was published in GSR 763 (e) by the India Ministry of Health and Family Welfare and enforced from December 15th, 2020. The new rules have streamlined, clarified the regulatory requirements and standards on the import, manufacture, and distribution of cosmetics in India. The new rules enhance accountability for importers and manufacturers with respect to the quality of their cosmetic products. The digitalization of the regulatory process going forward is also bound to increase efficiencies and make the application process smooth and less time-consuming to the importers and manufacturers. To help enterprises better cope with the Cosmetic Rules 2020, ChemLinked invited Ms. Rucha Kelkar, the founder of Praha Regulatory Consultants, to detail the key changes brought by the new rules, the regulatory requirements of imported cosmetics, and advice on regulatory compliance. Contents Cosmetic market in India Introduction to the Cosmetics Rules 2020 Comparisons between the old and new rules…

Apr. 22nd, 2021

Indonesian Food Imports: Licensing and Labeling Requirements

Background To ensure the safety and quality of food products entering the country, the Government of Indonesia, through the food and drug supervisory agency (Badan Pengawas Obat dan Makanan or “BPOM”) and various ministries, requires business actors to obtain certain licenses and comply with labeling requirements. With changes to the licensing process through the Online Single Submission system and BPOM’s online system, importers of food products need to understand the licensing process procedures and requirements and the documents required for business actors to comply with the laws and regulations concerning food imports in Indonesia. Contents 1. Investment opportunities in the importation of food products; 2. Food import laws and regulations; 3. Categorization of food products under BPOM regulations; 4. Key licenses for the importation of food products (business identification number, business license, marketing authorization, import permit); 5. Procedures and requirements to obtain licenses; and 6. Labeling requirements. Schedule Date Time (GMT 8) World Clock Language 2021-05-18…

Apr. 22nd, 2021

Page 28 of 40 FirstPrev...1020...2627282930...40...NextLast
  • 문의하기
  • +82-02-6245-1610
  • korea@reach24h.com

TSCA Inventory Search Tool

문의하러 가기

  • + 82-2-6245-1610
  • korea@reach24h.com
  • 서울시 강남구 강남대로94길 34, 4층 리이치24시코리아 |
    4F, 34 Gangnam-daero 94-gil, Gangnam-gu, Seoul, Republic of
    Korea
  • REACH24H

회사 소개

서비스 & 업계

뉴스

자원 센터

  • About Us

산업용 화학물질

  • 제품 등록
  • 제품 안전성

농업용 화학물질

  • 살충제 등록
  • 살생물제 등록
  • 비료 등록
  • 규제 대응

식품 및 식품 접촉물질

  • 제품 등록
  • 규제 대응

화장품

  • 제품 등록
  • 규제 대응
  • 회사 뉴스
  • 업계 뉴스
  • ChemLinked
Copyright © 2025 REACH24H Consulting Group | Powered by REACH24H Consulting Group